Biofrontera Inc banner

Intrinsic Value

The intrinsic value of Biofrontera Inc (BFRI) under the Base Case is 6.614 USD per share. Compared with the current market price of 0.9315 USD, the stock appears Undervalued by 86% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

BFRI Intrinsic Value
$6.614
Undervaluation 86%
Intrinsic Value
Price $0.9315

BFRI is cheaper than usual. It was this cheap or cheaper on just 15% of days in the past 3 years.

Monitor BFRI
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $5.29
Get notified when the price drops into your buy zone
Intrinsic Value $6.61
Margin of Safety 20% $5.29
Current Price $0.93
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BFRI

Fundamental Analysis

What Biofrontera Does

Pharmaceuticals Health Care

Biofrontera Inc. is a dermatology company that sells prescription products and device systems used by skin doctors, mainly for treating actinic keratosis, a common sun-related precancerous skin condition. Its main product is Ameluz, a topical drug used with a special red-light lamp in photodynamic therapy, along with the light device and related accessories that doctors use in treatment rooms.

Headquarters
United States of America US
Employees
89
IPO date
Oct 14, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Biofrontera Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one BFRI stock?

The intrinsic value for Biofrontera Inc (BFRI) under the Base Case is 6.614 USD.

Is BFRI stock undervalued or overvalued?

Compared with the current market price of 0.9315 USD, the stock appears Undervalued by 86% .

Back to Top